Skip to main content
Lab Grimoire
TW EN
Coffee

LDH Cytotoxicity Assay

Quantifies plasma membrane disruption by measuring lactate dehydrogenase (LDH) released from cells with compromised membranes into culture supernatant. LDH activity is detected using a coupled diaphorase/INT colorimetric reaction, generating a red formazan product measured at 490 nm. Uses a 96-well microplate format with two required controls: Spontaneous Release (untreated cells) and Maximum Release (fully lysed cells). Cytotoxicity percentage is calculated from these benchmarks with background correction via a Volume Correction control (medium only).

cell-culture Beginner 3–4 hours (including treatment period) 8 steps
Materials 5 · Equipment 8

Materials

  • Complete growth mediumSame medium used for cell culture
  • Lysis solution (10× stock; e.g., 1% Triton X-100 or commercial equivalent)Dilute 1:10 in medium for 0.1% working solution (Maximum Release wells)
  • LDH Substrate Reaction Mixture (lactate, NAD⁺, diaphorase, INT in buffer)Commercial kit or prepare from components; store at −20°C; protect from light; prepare fresh
  • Stop Solution (1 N acetic acid, or commercial equivalent)Terminates enzymatic reaction; may be prepared fresh from glacial acetic acid
  • Phosphate-buffered saline (PBS), pH 7.4For washing if required by cell protocol

Equipment

  • Microplate readerMust accommodate 490 nm primary filter; 600–690 nm reference filter recommended
  • 96-well flat-bottom tissue culture plateFor cell seeding and treatment
  • 96-well flat-bottom clear assay plate (non-TC-treated)For LDH enzyme colorimetric reaction
  • Centrifuge with 96-well plate carrier (swinging-bucket preferred)For pelleting cells/debris before supernatant transfer
  • CO₂ incubator (37°C, 5% CO₂)For cell culture and treatment
  • Multichannel pipette (8- or 12-channel, 50–200 µL range)For rapid uniform supernatant transfer
  • Aluminum foilTo protect light-sensitive reagents during incubation steps
  • Hemocytometer or automated cell counterFor seeding density verification

Done 0 / 8 steps

Stage 01 / 05SEED

Seed the culture plate

A consistent monolayer keeps basal and total LDH release comparable across wells.

  1. STEP 1Seed cells in 96-well plateDay −1; ~30 min hands-on

    Prepare a single-cell suspension of the target cell type at the desired density (typically 1×10³–2×10⁴ cells/well; optimize for cell type and treatment duration). Add 100 µL of complete growth medium per well. Distribute cells into all Experimental (E), Spontaneous Release (SR), and Maximum Release (MR) wells. Add medium only to Volume Correction (VC) wells. Incubate overnight at 37°C, 5% CO₂ to allow adherent cells to attach.

    WhyConsistent seeding density is critical — variation in cell number directly affects both SR and MR readings, inflating inter-replicate variance. Overnight attachment ensures a uniform monolayer before treatment (Korzeniewski & Callewaert, 1983).

    CautionFor suspension cell lines, omit overnight adhesion step; instead, verify viability > 90% by trypan blue exclusion or equivalent before seeding, and do not centrifuge the culture plate in Step 5 — see Critical Note 8.

Stage 02 / 05CONTROLS

Set controls and lyse MR wells

Untreated cells establish spontaneous release, medium-only wells correct the background, and lysed cells set the maximum-release reference.

  1. STEP 2Add treatments and set up experimental groupsDay 0; ~30 min

    Prepare all treatment solutions at 2× final concentration in complete medium. Add treatments to designated wells (replace or supplement existing medium as required). Set up the four required control well types:

    Well Type Contents Purpose
    Spontaneous Release (SR) Untreated cells + vehicle (same volume as treatment) Baseline LDH leakage reference
    Maximum Release (MR) Untreated cells (lysis solution added in Step 3) 100% cytotoxicity reference
    Volume Correction (VC) Medium only, no cells Background LDH from serum/medium
    Experimental (E) Treated cells Test condition

    Incubate for the desired treatment duration at 37°C, 5% CO₂.

    WhySR corrects for constitutive LDH release; MR normalizes to total cellular LDH content. Both controls must derive from the same cell batch and seeding event as the experimental wells. VC corrects for serum-derived LDH activity present in the medium (Decker & Lohmann-Matthes, 1988).

  2. STEP 3Lyse Maximum Release wells45–60 min before end of treatment

    Prepare working lysis solution at 1:10 dilution in complete medium (e.g., 0.1% Triton X-100 final concentration, or per commercial kit instructions). Add lysis solution to MR wells at a volume equal to the existing medium volume (e.g., 10 µL 10× stock into 100 µL medium = 0.1% final). Return plate to incubator for the remaining 45–60 min of treatment.

    WhyLDH equilibration from lysed cells into supernatant requires incubation time. A 45–60 min window at 37°C ensures complete LDH release and homogeneous distribution in the well volume before supernatant collection (Cummings & Schnellmann, 2021).

    CautionDo not add lysis solution to Experimental or SR wells. Change pipette tips between wells to prevent cross-contamination of lysis reagent.

Stage 03 / 05TRANSFER

Clarify and transfer the supernatant

Pelleting detached cells keeps debris from inflating soluble LDH readings.

  1. STEP 4Equilibrate plate at room temperature30 min

    Remove plate from incubator and place on the benchtop. Allow plate to equilibrate at room temperature for 30 minutes without agitation.

    WhyTemperature affects LDH enzyme kinetics. Equilibrating all wells to the same ambient temperature before supernatant transfer ensures consistent substrate reaction rates across replicate wells during the colorimetric assay step (Cummings & Schnellmann, 2021).

  2. STEP 5Centrifuge plate and transfer supernatant~10 min

    Centrifuge the 96-well culture plate at 250 × g for 4 minutes to pellet detached cells and debris. Using a multichannel pipette, carefully transfer 50 µL of clarified supernatant from each well to corresponding wells in a clear, flat-bottom, non-TC-treated assay plate. Aspirate from the surface of the supernatant; do not disturb the cell pellet. Include VC wells (medium only): transfer 50 µL to the assay plate as well.

    WhyCell debris in the supernatant contains additional intracellular LDH and would artifactually over-report cytotoxicity. Centrifugation removes particulate matter without loss of soluble LDH (Korzeniewski & Callewaert, 1983).

    CautionUse a swinging-bucket rotor if available to ensure uniform cell pelleting across all wells. Fixed-angle rotors may leave debris unevenly distributed and increase pipetting error.

Stage 04 / 05REACTION

Develop and stop the color reaction

LDH generates NADH, then diaphorase uses it to reduce INT into red formazan.

  1. STEP 6Add LDH Substrate Reaction Mixture and incubate20–30 min

    Reconstitute or prepare LDH Substrate Reaction Mixture according to manufacturer's protocol or published formulation. Prepare immediately before use; protect from light. Add 50 µL of LDH Substrate Reaction Mixture to each well of the assay plate (E, SR, MR, and VC wells). Cover the assay plate immediately with aluminum foil. Incubate at room temperature, protected from light, for 20–30 minutes. Monitor color development: SR wells should show a pale pink tint; MR wells should develop a clearly visible red color. If MR wells remain pale after 30 min, extend incubation in 5-min increments, checking every 5 min.

    WhyThe INT/diaphorase reaction is driven by LDH-generated NADH. A 20–30 min endpoint at room temperature is sufficient for near-linear signal development across the expected LDH concentration range (Decker & Lohmann-Matthes, 1988).

    CautionThe INT component is photosensitive. Direct light exposure generates background formazan independent of LDH activity, elevating all readings. Keep reagents and the assay plate covered at all times after reconstitution.

  2. STEP 7Add Stop Solutionimmediate

    Add 50 µL of Stop Solution (1 N acetic acid) to each well in the same order and approximate timing as the substrate was added. Tap the plate gently to mix. Visually verify the expected color gradient: VC (colorless) ≤ SR (pale pink) ≪ MR (bright red); Experimental wells should fall between SR and MR.

    WhyThe acidic Stop Solution protonates the diaphorase active site and inhibits further NADH oxidation, fixing the formazan endpoint. Maintaining consistent elapsed time between substrate addition and stopping across all wells is critical for quantitative reproducibility.

    CautionIf any Experimental well appears darker red than MR wells, the assay has been saturated. Dilute the supernatant 1:2 or 1:5 in medium and repeat from Step 5.

Stage 05 / 05READOUT

Read absorbance and calculate cytotoxicity

Subtract the VC background from E, SR, and MR before normalizing experimental release to the SR and MR range.

  1. STEP 8Read absorbance and calculatewithin 60 min

    Set microplate reader to primary wavelength: 490 nm; reference wavelength: 600–690 nm. Read absorbance within 60 minutes of adding Stop Solution. Record raw OD values for all wells. Subtract VC mean from all E, SR, and MR readings (background correction). Calculate % Cytotoxicity for each experimental condition:

      % Cytotoxicity = (E_corrected − SR_corrected) / (MR_corrected − SR_corrected) × 100
    

    Report mean ± SD across replicates (minimum n = 3 biological replicates recommended).

    WhyFormazan is stable in acidic conditions immediately after stopping, but slow non-enzymatic re-oxidation occurs over time, increasing background in high-LDH wells. Reading within 60 minutes ensures absorbance values reflect the stopped enzymatic endpoint accurately.